![](/img/cover-not-exists.png)
Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study
Meulendijks, Didier, de Groot, Jan Willem B., Los, Maartje, Boers, James E., Beerepoot, Laurens V., Polee, Marco B., Beeker, Aart, Portielje, Johanna E.A., Goey, Swan H., de Jong, Robert S., VanhoutviVolume:
122
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.29864
Date:
May, 2016
File:
PDF, 344 KB
english, 2016